FDA Drug · D-0660-2026

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.

Class II · Ongoing

Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.

Affected lots / codes — check yours against thisLot#: 25285401A, Exp. Date: 04/2027

Recalling firm: Lannett Company Inc., Seymour, IN
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 1392 bottles
Distribution: US Nationwide.
Recall initiated: June 26, 2026
Classified: July 2, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0660-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →